Jan Kuhlmann Andersen is the COO of BioPorto Diagnostics A/S is an in-vitro diagnostics company that provides healthcare professionals in clinical and research settings a range of diagnostic tests and antibodies. Jan Kuhlmann has 20 years experience from the pharmaceutical and biotechnological industry, he has had several senior management and key leadership positions in the Nunc Group, Fischer Scientific Products, FMC and Dako within sales, production and life science product development. Jan Kuhlman also held the Managing Director position at Cambrex Bioresearch Europe 2000-2003. Since 2007 Jan Kuhlmann was the Vice President, Sales & Marketing, Animal Health & Nutrition at Christian Hansen A/S, Denmark. Until January 1, 2015, Jan Kuhlmann Andersen was also a Board member in Noscomed Medical Supply A/S and in the French Life Science company Cell Made. Jan Kuhlmann holds both a M.Sc. and Ph.D. in cell biology and Immunology from the University of Copenhagen.
Per Falholt is Chairman of the Board at Universe, he has been Chairman of the Board at the Danish Technical University since 2013, and is also a Boardmember at Danfoss. Per Falholt is the Founder of Per Falholt Global R&D Advisory Services. He was Executive Vice President at Novozymes, Research & Development, 2000-2016, Senior Vice President at Novo Nordisk, 1999-2000 and Director at Novo Nordisk, 1991-1999. As Chief Science Officer at Novozymes, Mr. Falholt helped Novozymes develop a unique industrial biotechnology platform which delivers solutions to meet customer needs and support growth. Mr. Falholt holds a M.Sc. in Chemical Engineering from Technical University of Denmark (DTU). He was appointed Honorary Professor at DTU’s Institute for Systems Biology in 2010-2014.
Lars-Christian is an experienced investment banker with many years as head of Europe, England, Denmark and the Nordic Region. Lars-Christian has lived in England and the US for over fifteen years. He is now based in Denmark and acts a professional board member in 14 companies (nine as chairman) that spans from the building and construction industry to ecological agriculture over the media and the utility industry. Lars-Christian is also Vice-mayor of Roskilde Kommune and a candidate for the Parliament at the next general election.
Peter Bonne Eriksen holds a MSc in Chemical Engineering from the Technical University of Copenhagen specialized in biotechnology. Further he has a bachelor degree from the Copenhagen Business School with management and strategy development. He has for more than 15 years up until 2014 held senior vice president positions at Novo Nordisk within drug development and regulatory affairs, and has extensive experience in dealing with regulatory agencies world wide. He has been member of the board of EuropaBio. Peter Eriksen is the owner and founder of Peter Bonne Eriksen Consultancy providing advice and services to biotech companies.
Lars Bjerrek has a Master in Public and Business Law from the University of Gothenburg and has spent over 30 years in the financial industry covering both business and investment banking as well as asset and wealth management. Lars has spent almost 50% of his carrier on international assignments working for companies like SEB, Carnegie, Nordea and Öhman. Lars has during the last 20 years held CEO or global business area head positions, and has deep knowledge regarding conditions for listed companies.Lars is today working as independent advisor and is also a Board member of Öhman Bank SA.